FDA Adverse Event Malfunction Summary report: N

COBAS C 503 ANALYTICAL UNIT

MDR report key: 20402209 · Received October 8, 2024

Report

Report Number
1823260-2024-02922
Event Type
Malfunction
Date Received
October 8, 2024
Date of Event
September 13, 2024
Report Date
January 24, 2025
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K191899
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE INVESTIGATION DETERMINED THE EVENT WAS DUE TO A COMBINATION OF THE ISSUES FOUND BY THE FIELD SERVICE ENGINEER AND POOR SAMPLE PRE-ANALYTICS. CORRECT PRE-ANALYTIC SAMPLE HANDLING IS WITHIN THE CUSTOMER'S RESPONSIBILITY.

Additional Manufacturer Narrative · 0

THE CALCIUM REAGENT LOT NUMBER WAS 803015. THE CREATININE REAGENT LOT NUMBER AND THE EXPIRATION DATES WERE NOT PROVIDED. THE FIELD SERVICE ENGINEER FOUND WHITE DEPOSITS ON THE SAMPLE PROBE. HE REPLACED AND ADJUSTED THE PROBE AND VERIFIED THE WASHING STATION AND VACUUM BOTTLE WERE ACCEPTABLE. THE CUSTOMER PERFORMED CALIBRATION AND QC WHICH WERE BOTH ACCEPTABLE. THE INVESTIGATION IS ONGOING.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF QUESTIONABLE RESULTS FROM THE COBAS C 503 ANALYTICAL UNIT. EXAMPLE 1 INITIAL CALCIUM GEN.2 RESULT WAS 1.63 MMOL/L AND THE REPEAT RESULT WAS 2.05 MMOL/L. EXAMPLE 2 INITIAL COBAS CREATININE PLUS VER.2 ASSAY RESULT ON (B)(6) 2024 WAS 172. MOL/L AND THE REPEAT RESULT ON (B)(6) 2024 WAS 93.1 MOL/L. EXAMPLE 3 INITIAL CALCIUM RESULT WAS 1.92 MMOL/L AND THE REPEAT RESULT WAS 1.59 MMOL/L. EXAMPLE 4 INITIAL CALCIUM RESULT WAS 1.77 MMOL/L AND THE REPEAT RESULT WAS 2.28 MMOL/L.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
718453 COBAS C 503 ANALYTICAL UNIT CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS

Patients

Seq Age Sex Outcome Treatment
1 78 YR Unknown